Evidence map›Paper›PMID 20843783›Full record

ArticleNucleic acids research2011

Genome-wide mapping of RNA Pol-II promoter usage in mouse tissues by ChIP-seq.

Hao Sun, Jiejun Wu, Priyankara Wickramasinghe, Sharmistha Pal, Ravi Gupta, Anirban Bhattacharyya, Francisco J Agosto-Perez, Louise C Showe, Tim H-M Huang, Ramana V Davuluri

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Superenhancer drives a tumor-specific splicing variant of MARCO to promote triple-negative breast cancer progression.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. A stationary wavelet entropy-based clustering approach accurately predicts gene expression.Journal of computational biology : a journal of computational molecular cell biology · 2015
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Hao SunCenter for Systems and Computational Biology, Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA 19104, USA.
Jiejun Wu
Priyankara Wickramasinghe
Sharmistha Pal
Ravi Gupta
Anirban Bhattacharyya
Francisco J Agosto-Perez
Louise C Showe
Tim H-M Huang
Ramana V Davuluri
The Wistar Institute · USThe Ohio State University · US

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
Genomewide discovery & analysis of alternative promotersR01HG003362 · NHGRI · WISTAR INSTITUTE · PI DAVULURI, RAMANA V · 2006 to 2009
$1.3M
Comprehensive genomics using the Illumina Beadstation 500S10RR024693 · NCRR · WISTAR INSTITUTE · PI SHOWE, LOUISE C. · 2008 to 2008
$405k
NCI NIH HHS P30 CA010815NCRR NIH HHS S10 RR024693NHGRI NIH HHS R01 HG003362NHGRI NIH HHS R01HG003362
6 · The paper itself

Abstract

Alternative promoters that are differentially used in various cellular contexts and tissue types add to the transcriptional complexity in mammalian genome. Identification of alternative promoters and the annotation of their activity in different tissues is one of the major challenges in understanding the transcriptional regulation of the mammalian genes and their isoforms. To determine the use of alternative promoters in different tissues, we performed ChIP-seq experiments using antibody against RNA Pol-II, in five adult mouse tissues (brain, liver, lung, spleen and kidney). Our analysis identified 38 639 Pol-II promoters, including 12 270 novel promoters, for both protein coding and non-coding mouse genes. Of these, 6384 promoters are tissue specific which are CpG poor and we find that only 34% of the novel promoters are located in CpG-rich regions, suggesting that novel promoters are mostly tissue specific. By identifying the Pol-II bound promoter(s) of each annotated gene in a given tissue, we found that 37% of the protein coding genes use alternative promoters in the five mouse tissues. The promoter annotations and ChIP-seq data presented here will aid ongoing efforts of characterizing gene regulatory regions in mammalian genomes.

Indexed as

Promoter Regions, GeneticAnimalsChromatin ImmunoprecipitationChromosome MappingGenomeMiceRNA Polymerase IISequence Analysis, DNATranscription, GeneticRNA Polymerase II

Identifiers

PMID20843783
PMCPMC3017616
OpenAlexW2030879587

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.